Comment: Assessment of Changes in Utilization of Health-Care Services after Implementation of a Prior Authorization Policy for Atypical Antipsychotic Agents

Walthour A Seymour L Tackett R Perri M. Assessment of changes in utilization of healthcare services after implementation of a prior authorization policy for atypical antipsychotic agents. Ann Pharmacother 2010; 44: 809–18. DOI 10.1345/aph.1M620.

Kaiser Family Foundation. Medicare at a glance fact sheet. January 2010. www.kff.org/medicare/upload/1066-12.pdf (accessed 2010 Sept 30).

US Social Security Administration. Disability evaluation under Social Security (the Blue Book). www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm (accessed 2010 Sept 30).

Soumerai S B Zhang F Ross-Degnan D . Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Aff (Millwood) 2008; 27: w185–95.

Majumdar S R Lipton H L Soumerai S B . Evaluating and improving physician prescribing. In: Strom B , ed. Pharmacoepidemiology. 4th ed. Chichester, England: John Wiley and Sons, Ltd., 2005: 287.

Majumdar S R Lipton H L Soumerai S B . Evaluating and improving physician prescribing. In: Strom B , ed. Pharmacoepidemiology. 4th ed. Chichester, England: John Wiley and Sons, Ltd., 2005: Chapter 28.

Law M R Soumerai S B Ross-Degnan D Adams A S . A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry 2008; 69: 47–53.

Soumerai S B McLaughlin T J Ross-Degnan D Casteris C S Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331: 650–5.